Subtopic Deep Dive
Paraquat Lung Toxicity and Pulmonary Fibrosis
Research Guide
What is Paraquat Lung Toxicity and Pulmonary Fibrosis?
Paraquat lung toxicity refers to the selective accumulation of paraquat in lung tissue, triggering oxidative stress, inflammation, and progression to irreversible pulmonary fibrosis as the primary cause of death in poisoning cases.
Paraquat induces lung damage through redox cycling that generates superoxide radicals, leading to lipid peroxidation and fibrotic remodeling (Dinis-Oliveira et al., 2007, 891 citations). Animal models show dose-dependent progression from acute injury to chronic fibrosis within days (Bus and Gibson, 1984, 560 citations). Over 50 studies detail mechanisms, with biomarkers like NRF2 activation proposed for early detection.
Why It Matters
Paraquat poisoning causes 90% mortality from respiratory failure due to pulmonary fibrosis, guiding urgent clinical interventions like immunosuppression (Dinis-Oliveira et al., 2007). Resveratrol activates NRF2 to reduce fibrogenic responses in mouse models, suggesting antioxidant therapies (He et al., 2012, 168 citations). SIRT1 deacetylation of NRF2 protects alveolar cells, informing biomarker development for prognosis (Ding et al., 2016, 144 citations). These insights support poisoning prevention in agriculture and treatment protocols in toxicology centers.
Key Research Challenges
Redox Mechanism Variability
Paraquat's superoxide generation varies by cell type, complicating antioxidant therapy design (Bus and Gibson, 1984). Studies show Cu/Zn-SOD overexpression mitigates cytotoxicity but enhances lipid peroxidation (Elroy-Stein et al., 1986, 318 citations). Translating in vitro findings to human fibrosis remains inconsistent.
Fibrosis Progression Prediction
Early biomarkers for irreversible fibrosis are lacking despite histopathological models (Dinis-Oliveira et al., 2007). Inflammatory cascades lead to rapid lung remodeling, evading standard treatments (Smith et al., 1976, 192 citations). Clinical trials need validated predictors.
Therapeutic Intervention Timing
Lung transplantation fails due to paraquat persistence in grafts (Matthew et al., 1968, 180 citations). NRF2 activators like resveratrol show promise in vitro but require timing optimization (He et al., 2012). Delays in fibrosis onset hinder efficacy windows.
Essential Papers
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
Ricardo Jorge Dinis‐Oliveira, José Alberto Duarte, Amparo Sánchez Navarro et al. · 2007 · Critical Reviews in Toxicology · 891 citations
Paraquat dichloride (methyl viologen; PQ) is an effective and widely used herbicide that has a proven safety record when appropriately applied to eliminate weeds. However, over the last decades, th...
Paraquat: model for oxidant-initiated toxicity.
James S. Bus, Jack Gibson · 1984 · Environmental Health Perspectives · 560 citations
Paraquat, a quaternary ammonium bipyridyl herbicide, produces degenerative lesions in the lung after systemic administration to man and animals. The pulmonary toxicity of paraquat resembles in seve...
Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation.
Orna Elroy‐Stein, Yael Bernstein, Yoram Groner · 1986 · The EMBO Journal · 318 citations
Paraquat and Parkinson's disease
Colin Berry, Carlo La Vecchia, Pierluigi Nicotera · 2010 · Cell Death and Differentiation · 291 citations
Paraquat
Patrick F. Smith, Donald Heath, Alfred P. Fishman · 1976 · CRC Critical Reviews in Toxicology · 192 citations
The herbicide paraquat has claimed many fatalities due to accidental or deliberate ingestion of the concentrated form of the substance. Unlike most other poisons, the clinical course of paraquat in...
Paraquat Poisoning—Lung Transplantation
Henry Matthew, A.T. Logan, M. F. A. Woodruff et al. · 1968 · BMJ · 180 citations
A 15-year-old boy ingested a mouthful of paraquat and developed severe respiratory distress. Treatment included the transplantation of one lung, but subsequently changes developed in the graft whic...
Oxidant injury of lung parenchymal cells.
William J. Martin, James E. Gadek, Gary W. Hunninghake et al. · 1981 · Journal of Clinical Investigation · 180 citations
Hyperoxia and paraquat ingestion are two clinical examples of lung injury thought to be mediated by oxidant mechanisms. An in vitro cytotoxicity assay using freshly explanted 51Cr-labeled lung tiss...
Reading Guide
Foundational Papers
Start with Dinis-Oliveira et al. (2007, 891 citations) for comprehensive mechanisms and clinical features; follow with Bus and Gibson (1984, 560 citations) for oxidant model details; then Smith et al. (1976, 192 citations) for early toxicity patterns.
Recent Advances
He et al. (2012, 168 citations) on resveratrol-NRF2 protection; Ding et al. (2016, 144 citations) on SIRT1 in alveolar cells.
Core Methods
Redox cycling assays measure superoxide; histopathology scores fibrosis; transfected cell models overexpress SOD or NRF2 for protection testing (Elroy-Stein et al., 1986).
How PapersFlow Helps You Research Paraquat Lung Toxicity and Pulmonary Fibrosis
Discover & Search
Research Agent uses searchPapers('paraquat lung fibrosis mechanisms') to retrieve Dinis-Oliveira et al. (2007, 891 citations), then citationGraph to map 200+ citing works on oxidative pathways, and findSimilarPapers to uncover Bus and Gibson (1984) for redox models.
Analyze & Verify
Analysis Agent applies readPaperContent on He et al. (2012) to extract NRF2 data, runPythonAnalysis to plot dose-response curves from tables using pandas/matplotlib, and verifyResponse with CoVe for GRADE B evidence on resveratrol efficacy, plus statistical verification of lipid peroxidation metrics.
Synthesize & Write
Synthesis Agent detects gaps in SIRT1-NRF2 timing via contradiction flagging across Ding et al. (2016) and Elroy-Stein et al. (1986); Writing Agent uses latexEditText for fibrosis pathway revisions, latexSyncCitations for 891-citation integration, and latexCompile for publication-ready reviews with exportMermaid diagrams of inflammatory cascades.
Use Cases
"Analyze dose-response of paraquat on alveolar cell viability from key papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas curve fitting on Dinis-Oliveira et al. 2007 data) → matplotlib viability plots and IC50 stats.
"Write LaTeX review on paraquat fibrosis mechanisms with citations"
Synthesis Agent → gap detection → Writing Agent → latexEditText (draft pathways) → latexSyncCitations (Dinis-Oliveira 2007, Bus 1984) → latexCompile → PDF with fibrosis timeline figure.
"Find code for paraquat toxicity simulations in lung models"
Research Agent → paperExtractUrls (He et al. 2012) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on redox simulation scripts → verified oxidative stress model outputs.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'paraquat pulmonary fibrosis', structures reports with GRADE grading on Dinis-Oliveira et al. (2007), and flags treatment gaps. DeepScan applies 7-step CoVe to verify Bus and Gibson (1984) mechanisms with statistical checkpoints. Theorizer generates hypotheses on NRF2-SIRT1 synergies from He et al. (2012) and Ding et al. (2016).
Frequently Asked Questions
What defines paraquat lung toxicity?
Selective paraquat uptake via lung polyamine transporters causes redox cycling, superoxide production, and progression to fibrosis (Dinis-Oliveira et al., 2007).
What are main methods to study it?
In vitro assays use 51Cr-labeled lung explants for oxidant injury (Martin et al., 1981); animal models track fibrosis histopathology (Bus and Gibson, 1984).
What are key papers?
Dinis-Oliveira et al. (2007, 891 citations) reviews mechanisms; Bus and Gibson (1984, 560 citations) models oxidant toxicity; He et al. (2012, 168 citations) tests resveratrol.
What open problems exist?
No effective therapies halt fibrosis; biomarkers for early detection absent; human translation from rodent models inconsistent (Smith et al., 1976).
Research Paraquat toxicity studies and treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Paraquat Lung Toxicity and Pulmonary Fibrosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers